Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study

Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study Publisher Pubmed

Avagimyan A¹ ; Mkrtchyan L² ; Abrahomovich O³ ; Sheibani M⁴ ; Guevorkyan A¹ ; Sarrafzadegan N⁵ ; Kozhukhov S⁶ ; Agati L⁷ ; Astengiano R⁸ ; Zaritska V⁹ ; Jndoyan Z¹⁰

Show Affiliations

1. Internal Medicine Department, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia
2. Cardiology Department, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia
3. Internal Medicine Department, D. Halytsky Lviv National Medical University, Lviv, Ukraine
4. School of Medicine, Iran University of Medical Sciences, Teheran, Iran
5. Isfahan Cardiovascular-Research Center, Isfahan University of Medical Science, Isfahan, Iran
6. Clinical Pharmacology and Cardio-Oncology Department and Cardio-Oncology Center, M.D. Strazhesko Institute of Cardiology, Kiev, Ukraine
7. Sapienza University of Rome, Rome, Italy
8. School of Medicine, Insubria University Varese, Lombardy, Italy
9. Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine
10. Internal Disease Propedeutics Department, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia

Source: Current Problems in Cardiology Published:2022

Abstract

In the period of dynamic development of pharmacological possibilities in the modern oncology, unfortunately, the issue of cardiotoxicity of chemotherapy did not lost its urgent value. Cardiotoxicity implies structural and functional myocardial alteration, together with an increase in the concentration of highly sensitive markers of myocardial necrosis, in particular T and I troponins, and N-terminal pro-BNP, as well as with a subclinical or clinical decrease in the LVEF. It is noteworthy that cardiotoxicity is manifested not only by the development of anthracycline cardiomyopathy with a high risk of convention into heart failure. It also can cause various cardiovascular pathologies, in particular cardiac syndrome X. This study described chemotherapy-induced microvascular angina in 23-year-old otherwise heathy woman. The diagnosis is challenging for doctors, since microvascular flow may be only detected by using functional test. © 2021 Elsevier Inc.

Related Docs

View other Related Docs

1. Anthracycline Associated Disturbances of Cardiovascular Homeostasis, Current Problems in Cardiology (2022)

2. Trimetazidine As a Modifier of Chemotherapy-Induced Cardiovascular Redox-Homeostasis Disturbances, Kardiologija v Belarusi (2022)

3. Alterations in the Echocardiographic Variables of the Right Ventricle in Asymptomatic Patients With Breast Cancer During Anthracycline Chemotherapy, Postgraduate Medical Journal (2017)

4. Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose, Current Drug Therapy (2020)

5. Pharmacological Interventions for Preventing Anthracycline-Induced Clinical and Subclinical Cardiotoxicity: A Network Meta-Analysis of Metastatic Breast Cancer, Journal of Oncology Pharmacy Practice (2021)

6. Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity, Journal of Research in Medical Sciences (2017)

7. Evaluation of Expression Level of Mir-3135B-5P in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity, Indian Journal of Clinical Biochemistry (2023)

8. Evaluation of Mir-146A As a Potential Biomarker for Diagnosis of Cardiotoxicity Induced by Chemotherapy in Patients With Breast Cancer, Journal of Research in Medical Sciences (2025)

Experts (# of related papers)

View all Related Experts

Nizal Sarrafzadegan (6)

Golnaz Vaseghi (3)

Style	Citing Format
MLA	Avagimyan A, et al.. "Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study." Current Problems in Cardiology, vol. 47, no. 9, 2022, pp. -.
APA	Avagimyan A, Mkrtchyan L, Abrahomovich O, Sheibani M, Guevorkyan A, Sarrafzadegan N, Kozhukhov S, Agati L, Astengiano R, Zaritska V, Jndoyan Z (2022). Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study. Current Problems in Cardiology, 47(9), -.
Chicago	Avagimyan A, Mkrtchyan L, Abrahomovich O, Sheibani M, Guevorkyan A, Sarrafzadegan N, Kozhukhov S, et al.. "Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study." Current Problems in Cardiology 47, no. 9 (2022): -.
Harvard	Avagimyan A et al. (2022) 'Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study', Current Problems in Cardiology, 47(9), pp. -.
Vancouver	Avagimyan A, Mkrtchyan L, Abrahomovich O, Sheibani M, Guevorkyan A, Sarrafzadegan N, et al.. Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study. Current Problems in Cardiology. 2022;47(9):-.
BibTex	@article{ author = {Avagimyan A and Mkrtchyan L and Abrahomovich O and Sheibani M and Guevorkyan A and Sarrafzadegan N and Kozhukhov S and Agati L and Astengiano R and Zaritska V and Jndoyan Z}, title = {Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study}, journal = {Current Problems in Cardiology}, volume = {47}, number = {9}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Avagimyan A AU - Mkrtchyan L AU - Abrahomovich O AU - Sheibani M AU - Guevorkyan A AU - Sarrafzadegan N AU - Kozhukhov S AU - Agati L AU - Astengiano R AU - Zaritska V AU - Jndoyan Z TI - Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study JO - Current Problems in Cardiology VL - 47 IS - 9 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract